| __timestamp | Agios Pharmaceuticals, Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 8494000000 |
| Thursday, January 1, 2015 | 141827000 | 9046000000 |
| Friday, January 1, 2016 | 220163000 | 9095000000 |
| Sunday, January 1, 2017 | 292681000 | 10554000000 |
| Monday, January 1, 2018 | 341324000 | 10775000000 |
| Tuesday, January 1, 2019 | 410894000 | 11355000000 |
| Wednesday, January 1, 2020 | 367470000 | 12340000000 |
| Friday, January 1, 2021 | 256973000 | 14277000000 |
| Saturday, January 1, 2022 | 279910000 | 14135000000 |
| Sunday, January 1, 2023 | 288903000 | 15048000000 |
| Monday, January 1, 2024 | 301286000 | 17232000000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Johnson & Johnson and Agios Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Johnson & Johnson consistently allocated a significant portion of its resources to R&D, with expenditures growing by approximately 77%, peaking at $15 billion in 2023. This robust investment underscores their dedication to maintaining a competitive edge in the global market.
Conversely, Agios Pharmaceuticals, Inc., a smaller player, has shown a more modest increase in R&D spending, with a 188% rise over the same period, reaching nearly $289 million in 2023. While their absolute spending is dwarfed by Johnson & Johnson, the relative growth highlights Agios's strategic focus on innovation to carve out its niche in the industry.
Comparing Innovation Spending: Novo Nordisk A/S and Agios Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Biogen Inc.
R&D Insights: How Johnson & Johnson and Ionis Pharmaceuticals, Inc. Allocate Funds
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Comparing Innovation Spending: Bio-Techne Corporation and Agios Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. or Agios Pharmaceuticals, Inc.: Who Invests More in Innovation?
PTC Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Vericel Corporation and Agios Pharmaceuticals, Inc.
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.